Alfadil Haroon: New Genetic Insights into Bone Marrow Failure Syndromes
Alfadil Haroon, Assistant Consultant of Hematology at King Faisal Specialist Hospital and Research Centre, Assistant Professor at Alfaisal University, shared a post on LinkedIn:
“Happy to share our book chapter titled ‘Newly Recognized Marrow Failure Syndromes‘ in the textbook on bone marrow failure syndromes.
This chapter reviews recently identified bone marrow failure syndromes described between 2012 and 2025, expanding beyond the classical conditions such as Fanconi anemia and Dyskeratosis congenita.
Advances in Next-Generation Sequencing have enabled the discovery of several novel genetic etiologies, including MYSM1, DNAJC21, ADH5/ALDH2, MECOM, ERCC6L2,TP53,OSM, and SAMD9/SAMD9L.
These findings are reshaping our understanding of inherited BMF, highlighting diverse clinical phenotypes, early onset cytopenias, and variable risks of progression to myeloid malignancies.
Improved genomic insights are helping clinicians refine diagnosis, risk assessment, and treatment strategies.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome